Table 3.
Safety outcomes.
| Outcome | Studies | Participants | Statistical method | Effect estimate |
|---|---|---|---|---|
| GI adverse reactions | 6 | 11575 | Odds ratio (Peto, fixed, 95% CI) | 1.06 [0.94, 1.20] |
| Treatment discontinuation | 6 | 11575 | Odds ratio (Peto, fixed, 95% CI) | 1.11 [0.96, 1.28] |
| Infections | 2 | 10198 | Odds ratio (Peto, fixed, 95% CI) | 1.04 [0.84, 1.28] |
| Myalgia | 4 | 4683 | Odds ratio (Peto, fixed, 95% CI) | 1.16 [0.99, 1.36] |
| Cancer | 2 | 10198 | Odds ratio R (Peto, fixed, 95% CI) | 0.97 [0.78, 1.21] |
| Myelotoxicity | 6 | 11307 | Odds ratio OR (Peto, fixed, 95% CI) | 1.01 [0.56, 1.80] |